Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
184.77
+8.72 (4.95%)
Nov 20, 2024, 4:00 PM EST - Market open
Inspire Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 755.59 | 624.8 | 407.86 | 233.39 | 115.38 | 82.05 | Upgrade
|
| Revenue Growth (YoY) | 32.52% | 53.19% | 74.75% | 102.28% | 40.62% | 62.18% | Upgrade
|
| Cost of Revenue | 115.05 | 96.58 | 66.12 | 33.28 | 17.62 | 13.64 | Upgrade
|
| Gross Profit | 640.54 | 528.22 | 341.74 | 200.12 | 97.76 | 68.41 | Upgrade
|
| Selling, General & Admin | 512.2 | 451.96 | 320.69 | 202.62 | 127.87 | 90.47 | Upgrade
|
| Research & Development | 114.84 | 116.54 | 68.65 | 37.35 | 26.09 | 12.84 | Upgrade
|
| Operating Expenses | 627.05 | 568.49 | 389.33 | 239.97 | 153.97 | 103.3 | Upgrade
|
| Operating Income | 13.5 | -40.27 | -47.59 | -39.85 | -56.21 | -34.9 | Upgrade
|
| Interest Expense | - | - | -1.68 | -2.13 | -2.12 | -2.12 | Upgrade
|
| Interest & Investment Income | 23.57 | 20.56 | 5.05 | 0.13 | 1.09 | 3.8 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.2 | -0.01 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | 0.01 | -0.04 | -0.12 | 0.15 | 0.01 | Upgrade
|
| Pretax Income | 37.06 | -19.91 | -44.27 | -41.97 | -57.09 | -33.2 | Upgrade
|
| Income Tax Expense | 4.01 | 1.25 | 0.61 | 0.07 | 0.12 | 0.04 | Upgrade
|
| Earnings From Continuing Operations | - | -21.15 | -44.88 | -42.04 | -57.2 | -33.24 | Upgrade
|
| Net Income | 33.05 | -21.15 | -44.88 | -42.04 | -57.2 | -33.24 | Upgrade
|
| Net Income to Common | 33.05 | -21.15 | -44.88 | -42.04 | -57.2 | -33.24 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 29 | 28 | 27 | 26 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 29 | 28 | 27 | 26 | 24 | Upgrade
|
| Shares Change (YoY) | 3.93% | 4.38% | 2.97% | 4.56% | 9.53% | 63.27% | Upgrade
|
| EPS (Basic) | 1.11 | -0.72 | -1.60 | -1.54 | -2.19 | -1.40 | Upgrade
|
| EPS (Diluted) | 1.09 | -0.72 | -1.60 | -1.54 | -2.19 | -1.40 | Upgrade
|
| Free Cash Flow | 38.2 | 1.02 | 2.47 | -24.79 | -55.5 | -35.59 | Upgrade
|
| Free Cash Flow Per Share | 1.26 | 0.03 | 0.09 | -0.91 | -2.13 | -1.49 | Upgrade
|
| Gross Margin | 84.77% | 84.54% | 83.79% | 85.74% | 84.73% | 83.37% | Upgrade
|
| Operating Margin | 1.79% | -6.45% | -11.67% | -17.07% | -48.72% | -42.53% | Upgrade
|
| Profit Margin | 4.37% | -3.39% | -11.00% | -18.01% | -49.58% | -40.52% | Upgrade
|
| Free Cash Flow Margin | 5.06% | 0.16% | 0.61% | -10.62% | -48.10% | -43.37% | Upgrade
|
| EBITDA | 18.39 | -37.43 | -45.73 | -38.63 | -55.37 | -34.4 | Upgrade
|
| EBITDA Margin | 2.43% | -5.99% | -11.21% | -16.55% | -47.99% | -41.93% | Upgrade
|
| D&A For EBITDA | 4.89 | 2.85 | 1.86 | 1.22 | 0.84 | 0.5 | Upgrade
|
| EBIT | 13.5 | -40.27 | -47.59 | -39.85 | -56.21 | -34.9 | Upgrade
|
| EBIT Margin | 1.79% | -6.45% | -11.67% | -17.07% | -48.72% | -42.53% | Upgrade
|
| Advertising Expenses | - | 100.3 | 74.3 | 47.8 | 26.4 | 18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.